MEDEVIS

The code(s) and term(s) in this section were observed and retrieved from public databases and have not been validated by health regulatory authorities. Please consult your regulatory agency and EMDN site: https://webgate.ec.europa.eu/dyna2/emdn

GMDN related code(s)

48444

HIV1/HIV2 nucleic acid IVD, reagent (A substance or reactant intended to be used together with a parent IVD to perform a specific function in an assay that is used for the qualitative and/or quantitative detection of nucleic acid from human immunodeficiency virus 1 and 2 (HIV1/HIV2) in a clinical specimen.)

The medical device term(s), code(s) and definition(s) in this section were retrieved from databases external to WHO. As there might be more than one name, definition and “Nomenclature Code” related to the specific medical device, please consult https://gmdnagency.org GMDN ®. © GMDN Agency 2005-2025

WHO related resources

https://apps.who.int/iris/bitstream/handle/10665/75206/9789241593877_eng.pdf;sequence=1 http://apps.who.int/iris/bitstream/10665/75971/1/9789241504522_eng.pdf https://apps.who.int/iris/bitstream/handle/10665/329527/9789241210317-eng.pdf https://www.who.int/health-topics/diagnostics#tab=tab_1

Decommissioning

https://youtu.be/D7TycnSGGXc https://apps.who.int/iris/handle/10665/330095

WHO resources on medical devices

Interagency list of priority medical devices for essential interventions for reproductive, maternal, newborn and child health WHO list of priority medical devices for cancer management WHO List of Priority Medical Devices for management of cardiovascular diseases and diabetes WHO List of Priority medical devices list for the COVID-19 response and associated technical specifications Package of eye care interventions Trauma and Emergency Surgery Kit (TESK) 2019 WHO medical devices website WHO priority medical devices website WHO essential in vitro diagnostic website

Export

Reagents, HIV quantitative NAT